Zextras Carbonio Community Edition: One of the Best FOSS Digital Workplace and Email Platforms for Private Communication and Collaboration
Zextras, a leader in developing innovative email solutions, proudly announces the launch of Carbonio Community Edition (CE), a cutting-edge, fully open-source digital workplace platform designed to enable organizations to self-host their collaboration environment for heightened privacy and control. Carbonio CE offers unparalleled privacy for businesses looking for arobust alternative to
-
Open-source solutions such as
- Zimbra OSE
-
or SaaS solutions such as
- G Suite
- Microsoft 365 Online.
As a FOSS (Free and Open Source Software) solution, Carbonio CE grants users complete control over their software infrastructure, enabling customization and integration that align with any company's specific requirements.
Features
This powerful platform integrates essential communication tools such as
- Calendars
- Contacts
- Tasks
- Chats
- Video chats
Facilitating a cohesive environment where team members can easily connect and collaborate from any location whether viaweb clientormobile devices. Privacy and security are at the forefront of Carbonio CE's design, ensuring that sensitive data is kept confidential and safeguarded against unauthorized access.
Enterprise-Grade Solution
Zextras has harnessed the power of open-source technology, offering businesses of all sizes an enterprise-grade solution without the enterprise-level costs. Carbonio CE's scalable architecture ensures that it can effortlessly adapt to organizations' evolving needs, making it ideal for small to medium businesses (SMBs).
In addition to the natively available features, Carbonio CE is bolstered by Zextras' celebrated expertise in email solutions and collaboration systems. This new offering is set to revolutionize how businesses communicate internally and is a testament to Zextras' dedication to delivering first-rate technological solutions.
Availability
Carbonio CE is now available for download, enabling businesses to take their first step toward a more secure, efficient, and collaborative digital workplace.
For more information about Carbonio Community Edition and how it can transform your organization's communication infrastructure, please visit https://lp.zextras.com/carbonio-ce/?utm_source=business_wire&utm_medium=pr&utm_campaign=carbonio_ce_launch
About Zextras
Zextras is an industry-leading software development company that specializes in creating advanced solutions designed to enhance digital communication and collaboration platforms. With a strong focus on user privacy and open-source technology, Zextras is committed to providing sophisticated yet intuitive tools that cater to the demands of an evolving digital landscape.
For more information, please visit https://lp.zextras.com/carbonio-ce/?utm_source=business_wire&utm_medium=pr&utm_campaign=carbonio_ce_launch
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240205278531/en/
Contact information
Media Contact Details
Paolo Storti
CEO
marketing@zextras.com
Zextras
http://www.zextras.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom